Drug & medication recalls Moderate risk

WP Thyroid recalled over manufacturing violations

Recall date
August 25, 2020
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
RLC Labs Inc. recalls WP Thyroid, Westhroid Pure, 3/4 Grain (48.75 mg) Thyroid USP, packaged in a) 1,000 Tablets, NDC 64727-5650-2 ; b) 30 Ta…
Recall number
D-1608-2020
FDA classification
Class II
Brand / firm
RLC Labs Inc.
Sold / distributed
Nationwide in the United States

Why it was recalled

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

WP Thyroid, Westhroid Pure, 3/4 Grain (48.75 mg) Thyroid USP, packaged in a) 1,000 Tablets, NDC 64727-5650-2 ; b) 30 Tablets, NDC 64727-5650-4; c) 60 Tablets, NDC 64727-5650-5; d) 90 Tablets, NDC 64727-5650-6; e) 100 Tablets, NDC 64727-5650-1; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034

Get recall alerts

Free email alert whenever RLC Labs Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: RLC Labs Inc.